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ABSTRACT
STAT5 interacts with other factors to control tran-
scription, and the mechanism of regulation is of in-
terest as constitutive active STAT5 has been reported
in malignancies. Here, LSD1 and HDAC3 were iden-
tified as novel STAT5a interacting partners in pro-B
cells. Characterization of STAT5a, LSD1 and HDAC3
target genes by ChIP-seq and RNA-seq revealed gene
subsets regulated by independent or combined ac-
tion of the factors and LSD1/HDAC3 to play dual role
in their activation or repression. Genes bound by
STAT5a alone or in combination with weakly asso-
ciated LSD1 or HDAC3 were enriched for the canon-
ical STAT5a GAS motif, and such binding induced
activation or repression. Strong STAT5 binding was
seen more frequently in intergenic regions, which
might function as distal enhancer elements. Groups
of genes bound weaker by STAT5a and stronger by
LSD1/HDAC3 showed an absence of the GAS mo-
tif, and were differentially regulated based on their
genomic binding localization and binding affinities.
These genes exhibited increased binding frequency
in promoters, and in conjunction with the absence
of GAS sites, the data indicate a requirement for
stabilization by additional factors, which might re-
cruit LSD1/HDAC3. Our study describes an inter-
action network of STAT5a/LSD1/HDAC3 and a dual
function of LSD1/HDAC3 on STAT5-dependent tran-
scription, defined by protein–protein interactions,
genomic binding localization/affinity and motifs.
INTRODUCTION
Signal transducers and activators of transcription (STATs)
modulate transcription through signal transduction from
activated cell surface receptors to the nucleus and are key
components of various signal-transduction pathways (1,2).
The mammalian family of STATs includes seven members,
STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b and
STAT6, which are all encoded by distinct genes. STAT5 in-
cludes two highly related proteins, STAT5a and STAT5b,
sharing amino acid sequence similarity of more than 90%.
They exhibit both redundant and distinct physiological
functions, and they have been characterized mostly as tran-
scriptional activators, although they have been reported to
act also as transcriptional inhibitors (3,4).
Following stimulation, STAT5 proteins are rapidly
tyrosine-phosphorylated allowing homo- or hetero-
dimerization and translocation to the nucleus, where they
exert their transcriptional regulation role through specific
binding to DNA regulatory regions. STAT5 regulates a
plethora of target genes involved in cellular responses
to cytokines and growth factors, and its importance
is highlighted by the devastating effects resulting from
its aberrant constitutive activation in several forms of
leukemia, as well as in other malignancies (5–8). Therefore,
better understanding of the role and mechanism of action
of STAT5 in activation and repression of target genes is of
critical importance.
Studies in mouse models revealed a critical role for
STAT5. Complete STAT5a and STAT5b deficiency in mice
caused perinatal death and impaired lymphoid develop-
ment and function (9,10). Interestingly, B cell maturation
was abrogated at the pre-pro-B cell stage suggesting an im-
portant role for STAT5 in early B cell development. Fur-
thermore, transgenic mice expressing a constitutively active
form of STAT5b exhibit large increases in pro-B cells fur-
ther underlining its role in B cell differentiation (11).
Since both STAT5a silencing or over-expression have a
paramount effect on B cell development, it is important to
understand how STAT5a exerts regulatory control on its
target genes. The process of transcriptional programming
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involves cooperative binding of various transcription fac-
tors (12), and as such it is important to identify STAT5a
binding partners as co-regulators. Numerous STAT5 inter-
acting proteins have been identified and the interactions can
provide positive (13), negative (14) or no influence (15,16)
on STAT5-dependent transcription. Despite previous stud-
ies of STAT5 target genes in various cell types, data on
pro-B cells combining genome-wide binding and expression
analyses to define how specific protein interactions influ-
ence STAT5 target genes transcription are not available.
Therefore, we combined proteomics and genomics ap-
proaches, to obtain insights into the STAT5 mediated tran-
scriptionalmechanisms leading to activation and repression
of target genes. Such mechanisms might direct the phys-
iological functions of pro-B cells, which pave the way to
normal early B-cell development. Two novel STAT5a inter-
acting partners (LSD1 - Lysine specific demethylase 1, and
HDAC3 - Histone deacetylase 3) were identified in mouse
IL-3-dependent pro-B cells (Ba/F3). Their role on STAT5a
target genes regulation was investigated in a genome-wide
manner by correlating ChIP-seq data for STAT5a, LSD1
and HDAC3 with RNA-seq data in wild type (WT) and
knock-down (KD) Ba/F3 cells. Our results demonstrated
that LSD1 and HDAC3 possess dual roles in determining
transcriptional activation or repression of STAT5a target
genes, providing novel insights into the mechanisms of ac-
tivation and repression mediated by STAT5.
MATERIALS AND METHODS
Constructs, antibodies, primers and cell culture
The constructs and antibodies used can be found in Supple-
mentary Data. All primer sequences are available upon re-
quest. Ba/F3 cells (17) maintenance and BirA/bio-STAT5a
Ba/F3 cell clones generation and maintenance are previ-
ously described (18). The IL-3 deprivation condition of
Ba/F3 cells is defined as culturing cells in the absence of
IL-3 for 6 h, whereas the stimulation condition is defined as
culturing cells in the presence of 10 ng/ml IL-3 for 30 min
following the period of deprivation of IL-3 for 6 h.
Reverse transcription and real time PCR
Total RNA was extracted and reverse transcribed as pre-
viously described (19,20). Real-time polymerase chain re-
action (PCR) was performed with SYBR Green in an ABI
PRISM 7000 Sequence Detection System (Applied Biosys-
tems). The relative quantitation was performed using the
Ct method (21) and the housekeeping gene Hprt for
template normalization.
Nuclear and total cell extracts preparation
Nuclear extracts were prepared as previously described (22).
Total cell extracts were prepared with whole cell lysis buffer
(10 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 1 mM
Na3VO4, 10mMNaF, 5mMEDTA, 1mMPMSF and pro-
tease inhibitor cocktail (Roche)) for 30 min at 4◦C.
Gel filtration
Size fractionation of protein complexes was carried out on
an AKTA FPLC apparatus with a Superose 6 10/30 col-
umn (Amersham). Fractions were precipitated with 100%
trichloroacetic acid as previously described (23).
Immunoprecipitation, streptavidin precipitation and mass
spectrometry
Immunoprecipitation and isolation of the biotinylated
STAT5a protein with paramagnetic streptavidin beads was
performed as described previously (22). Boundmaterial was
analyzed by immunoblotting. A total of 10 mg of crude
nuclear extracts from BirA and BirA/bio-STAT5a Ba/F3
cells (stimulated with IL-3) were used for binding to strepta-
vidin beads undermoderate stringency conditions (150mM
NaCl/0.3% Nonidet P-40/200 ng/l chicken serum albu-
min). Proteins eluted from the streptavidin beads were sep-
arated by SDS/PAGE electrophoresis on an 8% polyacry-
lamide gel, processed for trypsinization and mass spectro-
metric analysis, as previously described (22).
Immunoblot analysis
Extracts (≥5 g/lane) or eluates from immuno- or strepta-
vidin precipitations were resolved by SDS/PAGE and blot-
ted onto Immobilon-P membrane (Millipore). Membranes
were blocked for 1 h in 5% milk/1x TBS/0.05% NP40 (or
5% BSA/1x TBS/0.05% NP40 for p-STAT5 antibody), in-
cubated overnight at 4◦C with primary antibodies, washed
in 1x TBS/0.5 M NaCl/0.3% Triton X-100 and then incu-
bated with secondary HRP conjugated antibodies. Bands
were detected using enhanced chemiluminescence (Amer-
sham Pharmacia). Densitometric quantitation of the sig-
nals was performed with Quantity One Software (Biorad)
and ImageJ.
In vitro transcription/translation and GST-pull down experi-
ments
HDAC3 and LSD1 were in vitro transcribed and trans-
lated using the TNT T7 Coupled Reticulocyte Lysate Sys-
tem (Promega). GST fusion proteins were expressed in
and purified from Escherichia coli BL21 cells according
to (24). Equal amounts of each fusion protein, immobi-
lized on glutathione-agarose beads, were incubated with
35S-HDAC3 or 35S-LSD1.After washes of the beads, bound
proteins were resolved by SDS-PAGE and visualized by au-
toradiography.
Short hairpin RNA-mediated knock-down experiments
The lentiviral particles were produced as previously de-
scribed (18) using pLKO.1 TRC control non-targeting vec-
tor (gift of Dr Papanikolaou), STAT5a (TRCN0000012549,
TRCN0000012550), STAT5b (TRCN0000012553), LSD1
(TRCN0000071376) and HDAC3 (TRCN0000039389)
clones of the TRC1 Library (Sigma, St. Louis, MO, USA).
Transductions of Ba/F3 cells were performed as described
(18).
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ChIPs, ChIP-seq and RNA-seq library construction
Chromatin streptavidin precipitation and ChIP experi-
ments were performed as previously described (18). The
ChIP-seq libraries (from two independent ChIP assays)
were constructed as previously described (25,26). The
RNA-seq libraries (3–5 replicates) were constructed using
the TruSeq RNA Sample Preparation kit v2 (Illumina RS-
122-2001) according to manufacturer’s instructions. All li-
braries were sequenced on the Illumina HiSeq 2000 high-
throughput sequencer.
NGS data analysis
Sequencing reads from ChIP-seq experiments were aligned
to the mouse genome (mm10) using Bowtie2 (27) and PCR
duplicates were removed. Peak calling and gene annotation
was performed using the Homer suite (28). Peak heatmaps
were produced with the use of Homer, cluster3 and Tree-
View for enrichment calculations, clustering and visualiza-
tion, respectively. MEME was used for de novo motif anal-
ysis (MEME-ChIP and CentriMo) (29). Sequencing reads
fromRNA-seq experiments were aligned to themouse tran-
scriptome (mm10), allowing for split reads, using TopHat2
(30). HTSeqwas used for expression quantification (31) and
DESeq2 for differential expression analysis with normaliza-
tion steps for eliminating batch effects (32). Gene set enrich-
ment analysis (GSEA) was performed using the pre-ranked
analysis option, and analyzing the gene-set identified by
the clustering of STAT5a peaks against the RNA-seq data
(33).More information regarding theNGSdata quality and
analysis is presented at Supplementary Data, and the code
used for the NGS analysis is available upon request. Data
fromNGS experiments have been deposited inGEO (acces-
sion number GSE79520).
Statistical analysis
Student’s t-test was performed for the statistical analysis of
ChIP enrichment data, unless stated otherwise.
RESULTS
Identification of novel STAT5a interacting proteins: LSD1
and HDAC3
To identify with high efficiency novel STAT5a interacting
partners in Ba/F3 cells in vivo biotinylation was applied
(Figure 1A). A bio-tag (22) was fused to STAT5a and co-
expressed with bacterial biotin transferase (BirA), which
specifically biotinylates the tagged protein. The biotin pro-
vided a very high affinity tag for the purification of in-
teracting partners, by virtue of its binding to streptavidin
(18,22). After verifying that the addition of the bio-tag does
not affect the functional properties of the STAT5a pro-
tein (Supplementary Figure S1), bio-STAT5a containing
nuclear complexes were isolated in a single-step purifica-
tion scheme by direct binding to streptavidin beads. Follow-
ing liquid chromatography and tandem MS, the proteins
identified specifically in BirA/bio-STAT5a cells included,
among others, factors involved in transcriptional regula-
tion and chromatin modification. In contrast, analysis of
the background binding proteins (from BirA control cells)
showed that the most abundant background proteins in-
clude the naturally biotinylated carboxylases and associated
enzymes, nuclear proteins involved in protein synthesis and
RNA post-transcriptional modification, mRNA processing
and ribosomal proteins. The full STAT5a interactors map
will be presented elsewhere (manuscript in preparation).
It is noteworthy that known STAT5 interacting partners
(HDAC1, BRG1, NFB and CBP) were included among
the identified proteins, validating our method. Here, the
physical and functional interactions of two novel STAT5a
interacting partners were characterized; HDAC3 (histone
deacetylase 3 (gi|6840851, gi|12643653, gi|89257352), score
104, unique/total peptides: 2/2) and LSD1 (Lysine-specific
histone demethylase 1 (gi|51315882) score 224, unique/total
peptides: 5/6).
The interactions of STAT5a with the novel partners
were confirmed by streptavidin precipitations in BirA/bio-
STAT5a and control BirA Ba/F3 nuclear extracts, followed
by immunoblots of the purified material with antibodies
specific for each identified partner (Figure 1B). The interac-
tions of the endogenous factors were verified by immuno-
precipitations of Ba/F3 extracts with anti-STAT5a anti-
body followed by immunoblot with antibodies specific for
the interacting partners, and confirmed with the reverse
experiment as well (Figure 1B). Furthermore, the DNA
binding-linker and the SH2 domains of STAT5a interact
with both partners, while the coiled-coil domain of STAT5a
only with HDAC3, as demonstrated by GST-pull down ex-
periments (Figure 1C). Additionally, high molecular weight
complexes containing STAT5a and the interacting partners
were identified by gel filtration chromatography suggesting
that all proteins could be part of the same high molecu-
lar weight complex or different (probably interacting) com-
plexes of the same size (Figure 1D).
Taken together, the above results demonstrate that
HDAC3 andLSD1 interact with STAT5a both in vivo and in
vitro, and these factors participate in high molecular weight
complexes.
STAT5a interactions with LSD1 and HDAC3 influence tran-
scription of target genes
ChIP-seq and RNA-seq experiments were then performed
and cross-correlated to investigate at a genome-wide level
the mechanisms of transcriptional regulation mediated by
STAT5a and HDAC3 or LSD1 (Figure 2, Supplementary
Figure S2; Tables S1, S2). In particular, STAT5a-regulated
genes that were also bound by LSD1 and/or HDAC3 were
identified and studied to decipher whether the interac-
tions influence STAT5-dependent transcription. ChIP-seq
experiments yielded a list of genomic locations bound by
STAT5a, LSD1 and/or HDAC3 under two conditions; de-
privation of IL-3 for 6 h or deprivation followed by IL-
3 stimulation for 30 min, which activates STAT5 (Figure
2, Supplementary Figure S3). To visualize these targets,
heatmaps were generated depicting the binding events (de-
creasing binding intensity values) for each specified factor
per condition (Figure 2A1, B2, C3, D4, E5, F6). Subse-
quently, the genomic locations for each factor per condi-
tion were obtained and the binding profiles for all the other
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Figure 1. Validation of STAT5a interactions with HDAC3 or LSD1. (A) Scheme for the specific biotinylation of bio-tagged STAT5a by the E.coli BirA
biotin ligase. The bio-tag is fused to the N-terminus of STAT5a. bio-tagged STAT5a and BirA, cloned separately under the control of EF1a promoter,
were co-expressed in Ba/F3 cells for protein complex purification. (B) Nuclear extracts from BirA/bio-STAT5a or BirA Ba/F3 control cells (deprived
of IL-3 for 6 h and then stimulated with IL-3 for 30 min) were precipitated with streptavidin (Strept) beads and immunoblotted with antibodies against
HDAC3 or LSD1 (top left), and immunoprecipitated with anti-STAT5a antibody or IgG control and immunoblotted with antibodies against HDAC3
or LSD1 (top right). The reverse immunoprecipitation experiment with antibodies against HDAC3, LSD1 or IgG control is also shown, immunoblotted
with anti-STAT5a antibody (bottom). (C) Graphical structure of GST-fused full length or sub-fragments of STAT5a are schematically shown (top). Au-
toradiographies of 35S-LSD1 (left), 35S-HDAC3 (right) pull-downs with GST-STAT5a full-length or sub-fragments and respective coomassie-stained gels
of purified GST-domains (bottom) are shown (DBD-L: DNA Binding-Linker, SH2: Src Homology 2, TAD: transactivation domain). (D) Gel filtration
size-fractionation profiles. Nuclear extracts from Ba/F3 cells (deprived of IL-3 for 6 h and stimulated with IL-3 for 30 min) were run on a Superose 6 col-
umn. The collected fractions following SDS/PAGE electrophoresis were immunoblotted with antibodies against HDAC3, LSD1 or STAT5a. Overlapping
complexes are indicated on the bottom by solid bars. Molecular mass markers are indicated on the top (Vo: Void volume).
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Figure 2. Heatmaps of STAT5a, LSD1 or HDAC3 bound regions and expression levels of target genes. ChIP-seq experiments (N = 2) were performed
of regions bound by STAT5a, LSD1 or HDAC3 (columns 1–6). Ba/F3 cells were cross-linked after either 6 h of IL-3 deprivation (−), or 6 h of IL-3
deprivation followed by 30 min IL-3 stimulation (+). (A–F) The heatmaps depict the enrichment of each factor (in red) at the peak summit, as well as at the
genomic region surrounding the peak summit (2 kb upstream and downstream the peak center) for all the significant peaks per condition, as mentioned
at the far left column. The enrichment values for each peak list were extracted from each library (indicated at the top row) with the significant peak list
per ChIP-seq library being at the diagonal (in black frames). The binding regions are sorted according to decreasing intensity from top to bottom for each
heatmap, being in the diagonal. RNA-seq experiments were performed in WT Ba/F3 cells (N = 5), as well as in STAT5a, STAT5b, LSD1, HDAC3 KD
cells (N = 3) and control shRNA-treated cells (N = 5) (column 7). All expression heatmaps represent log2FC values of the associated gene containing
or in proximity to each peak, as computed by DESeq2 (red depicts up-regulation and green down-regulation). Differential gene expression was analyzed
against IL-3 deprived cells in the case of WT Ba/F3 cells, and against cells treated with control no-target shRNA at the same condition for all the KD cells
(IL-3 stimulation). (G) Venn diagrams depict the direct overlap of the genomic peak coordinates between the two conditions for all factors.
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selected factors in both conditions at the same loci were de-
termined. For example in Figure 2, A1 panel demonstrates
the genomic locations bound by STAT5a in IL-3 deprived
cells. In A2, the same genomic locations are depicted, but
the binding intensity of STAT5a in IL-3 stimulated cells is
shown, in order to see the changes in binding between the
two conditions at the exact same binding sites. Similarly, in
panels A3 andA4, LSD1 binding under IL-3 deprivation or
post IL-3 stimulation, respectively, is visualized at the same
genomic locations, whereas A5 and A6 panels demonstrate
HDAC3 binding at these sites and so on.
This analysis confirmed the co-localization of STAT5a
with LSD1 and/or HDAC3 at many genomic sites, in par-
ticular for STAT5a binding events gained after IL-3 stim-
ulation (Figure 2, B4, B6 and corroboratively D2, F2).
Lower enrichment levels were seen in many STAT5a tar-
gets when considering HDAC3 binding and in particular
when that binding was compared to LSD1 binding at the
same genomic locations. The lower HDAC3 ChIP-seq sig-
nal, as seen in heatmaps, might indicate either weak bind-
ing or most probably indirect DNA binding through other
transcription factor hindering efficient detection. Neverthe-
less, the majority of HDAC3 targets (post IL-3 stimulation)
showed both strong STAT5a and LSD1 binding suggesting
either the existence of a complex containing all these factors
or their sequential occupancy on specific genomic locations
as a means of regulating expression.
Next, RNA-seq experiments were performed to corre-
late the binding events of the different factors to the ac-
tual expression levels of their target genes. The expres-
sion levels of WT Ba/F3 cells upon IL-3 stimulation were
first determined, revealing all genes that become activated
or repressed in response to IL-3. In addition, Ba/F3 cells
were also transduced with lentiviruses encoding shRNAs
to knock-down either STAT5a, STAT5b, HDAC3 or LSD1
(Supplementary Figure S4) for assessment of the functional
contribution of each factor’s binding to the regulation of
target genes expression. Hence, this allowed evaluation of
the loss-of-function effect for each factor by calculating the
fold difference in target genes expression after its KD, when
compared to no-target shRNA control, 30 min post IL-3
stimulation. For each gene exhibiting binding events from
either of the selected factors under study, its expression lev-
els were extracted from all the RNA-seq experiments and
presented in differential expression heatmaps sorted by the
ChIP-seq binding intensity (Figure 2, A7–F7). Genes were
classified as activated or repressed in WT Ba/F3 cells (Fig-
ure 2, A7–F7, left column and Supplementary Table S3)
and were further characterized by their change in expres-
sion at the stimulation state upon KDs (Figure 2, A7–F7,
right columns and Supplementary Table S3).
Examination of the expression levels of STAT5a target
genes revealed a correlation between strongly bound tar-
gets and gene activation upon IL-3 stimulation (Figure 2,
A1, A7 versus B2, B7). As expected, KD of STAT5a or
STAT5b led to inhibition of the genes activated by IL-3, as
compared to controls. Interestingly, KD of LSD1 resulted
in a widespread gene activation of STAT5a targets after IL-
3 stimulation (Figure 2, B7). This widespread activation is
seen in both STAT5a and LSD1 direct targets, but also, to a
much lesser extent, HDAC3 targets (Figure 2, D4, D7 and
F6, F7, respectively). This suggests that LSD1 is involved
in repression of specific genes in WT cells. Nonetheless, a
sub-population of the STAT5a targets exhibited reduced ex-
pression in the absence of LSD1 suggesting that LSD1 can
also function as an activator. Finally, HDAC3 KD appears
to promote gene activation of STAT5a and LSD1 targets to
a small degree (Figure 2, B7 and D7), whereas more sub-
stantial gene up-regulation is observed for genes that also
exhibit HDAC3 binding (Figure 2, E5, E7 and F6, F7).
Apart from identifying genomic locations that were
bound by one, combination of or all factors, interesting in-
formation about the changes of genomic targets occupancy
due to IL-3 stimulation was revealed (Figure 2G, Supple-
mentary Figure S3). In particular, IL-3 stimulation induced
de novo recruitment of STAT5a and only a small portion of
genomic targets was retained from the IL-3-deprived state.
As expected, the expression levels of the IL-3-induced de
novo genomic targets increased due to IL-3 and decreased
in the absence of STAT5a with the stronger binding corre-
lating to the greater differential expression (Supplementary
Figure S3A; STAT5a binding decreasing from top to bot-
tom of the heatmap). These targets presented increased in-
tergenic and intronic STAT5a binding and decreased pro-
moter binding compared to all other STAT5a targets (i.e.
targets with binding either in both conditions or during IL-
3 deprivation) suggesting binding in distant regulatory ele-
ments (Supplementary Figure S3B). Similar trend in terms
of expressionwas seen for the targets that exhibited STAT5a
binding in both conditions, albeit less pronounced, whereas
targets that exhibited STAT5a binding only post IL-3 de-
privation showed more diverse expression profiles. When
considering LSD1 recruitment, it is evident that more than
half of its genomic targets were retained in both condi-
tions indicating that LSD1 genomic interactions are only
in part influenced by IL-3 (Figure 2G, Supplementary Fig-
ure S3C and D). The de novo LSD1 recruitment induced
by IL-3 stimulation showed mainly increased expression in
WT Ba/F3 cells and, interestingly, weaker LSD1 genomic
binding appeared to promote activation in LSD1 KD cells
possibly indicating indirect LSD1 binding through a repres-
sor complex. On the other hand, HDAC3 recruitment was
decreased after IL-3 stimulation with only a few targets re-
tained in both conditions and a few more de novo targets
induced by IL-3 (Figure 2G, Supplementary Figure S3E
and F). Although differential expression of HDAC3 tar-
gets is seen, no clear preference in the expression profiles
of HDAC3 targets is detected suggesting that other factors
might be needed to predict the transcriptional outcome.
The above data defined a correlation of strong STAT5a
binding with gene activation. Furthermore, common
STAT5a, LSD1 and/orHDAC3 targets were defined. LSD1
and HDAC3 binding sites overlapped the STAT5a bind-
ing site and KDs of these factors suggested that LSD1 and
HDAC3 play a dual role in the regulation of targets’ expres-
sion. LSD1 and HDAC3 can act both as transcriptional co-
repressors and co-activators.
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Protein interactions and genomic binding influence STAT5a-
dependent transcription
To further examine the effect of LSD1 andHDAC3 in regu-
lation of STAT5a targets, a more thorough investigation of
the STAT5a targets was pursued by clustering the STAT5a
peaks according to targets enrichment values and expres-
sion levels in Ba/F3 cells (WT and KD cells). Using the k-
medians unsupervised clustering algorithm, groups of genes
with similar characteristics (ChIP-seq or RNA-seq data)
were identified in an attempt to find links between the bind-
ing pattern and expression profiles of the selected factors.
Furthermore, GSEA was performed to determine any pref-
erence for activation or repression (Supplementary Figure
S5). For the GSEA, all gene lists organized in clusters were
tested against the expression levels generated fromWT and
KD Ba/F3 cells (pre-ranked data) to identify any potential
enrichment in up- or down-regulated genes.
We identified 10 clusters of STAT5a targets, of which
clusters 1–7 displayed LSD1 and HDAC3 binding at the
same genomic location where STAT5a was bound. LSD1
appeared to bind more STAT5a targets than HDAC3, al-
beit weakly in some of the cases. Nonetheless, a similar
pattern was seen for both factors in terms of target bind-
ing and global expression levels after their KD (Figure 3
, Supplementary Figures S5 and S6). Clusters 1–3 included
strongly bound STAT5a targets (strongest binding was seen
in cluster 1, then cluster 2 and then cluster 3) and in-
duced by STAT5 (down-regulated in STAT5a and STAT5b
KDs) (Figure 3, Supplementary Figure S6). These genes
were weakly bound by LSD1 and HDAC3. Clusters 4–5 in-
cluded STAT5a-bound targets with lower enrichment val-
ues compared to clusters 1–3, but displayed strong LSD1
and HDAC3 binding. Importantly, KD of STAT5a, LSD1
and HDAC3 positively affected expression levels, whereas
STAT5b KD caused gene repression. Weaker LSD1 and
HDAC3 binding in combination to weaker STAT5a bind-
ing (clusters 6 and 7) was interesting, as LSD1 appeared to
act both as a repressor (cluster 6) and an activator (cluster
7) depending on the groups of genes, unlike HDAC3 that
seemed to exert little or no regulatory role (Supplementary
Figure S5). STAT5a (and STAT5b) had a similar effect on
these genes, as in KD cells significant enrichment was seen
in activated and repressed genes in clusters 6 and 7, respec-
tively. Overall, when considering all clusters exhibiting com-
monly bound targets by all factors (clusters 1–7), STAT5a
KDpromoted gene repressionwith the exception of clusters
4–5 and 6, and LSD1/HDAC3 KD promoted gene activa-
tion with noticeable exception being cluster 7. Finally, clus-
ters 8–10 included genes bound predominantly by STAT5a,
without any significant LSD1 or HDAC3 binding, which
were differentially affected by STAT5aKD and grouped ac-
cordingly. More specifically, in clusters 8 and 10 STAT5a
appeared to function as an activator, with the genes being
activated after IL-3 stimulation and repressed in the absence
of STAT5. Furthermore, both LSD1 and HDAC3 showed
differential regulation depending on the gene set, although
inmost cases they did not appear to significantly control the
transcriptional status of the genes. In cluster 9 on the other
hand, where activation in both LSD1 and HDAC3 KDwas
seen, an indirect mechanism of regulation most probably
dictated transcription, as there was no LSD1 or HDAC3
binding.
Together, these data strongly suggest that STAT5a has
both a positive and negative role in IL-3 stimulated gene
expression. Detailed characterization of STAT5a targets re-
vealed genes that are regulated by the combined action of
STAT5a, LSD1 and HDAC3. It appears that varying affin-
ity and combination of STAT5a, LSD1 and HDAC3 bind-
ing can differentially affect amplitude and direction of gene
expression of distinct set of genes.
Genomic binding positions and motifs influence STAT5a-
dependent transcription
To further understand the mechanisms of combinatorial
regulation of target genes by STAT5a, LSD1 and HDAC3,
the gene clusters obtained in Figure 3 were subjected to
DNA motif analysis, and identification of the genomic dis-
tribution of the peaks (Figure 3C, D and E). All clusters
showed a high enrichment of the gamma-activated sequence
(GAS), which STAT5a is known to bind to (TTC-NNN-
GAA), except for clusters 4–5, 6 and 7 (Supplementary Ta-
ble S4). Clusters 1–3 containing targets strongly bound by
STAT5a, weakly by HDAC3 and LSD1 and highly acti-
vated by STAT5a show a clear enrichment for the GAS
dimer motif (E-value = 1.3 × 10−708) indicating that these
geneswere bound directly by STAT5a dimers to induce their
expression. Enrichment for the GAS motif was also seen in
all the clusters exhibiting binding by STAT5a alone (clusters
8–10). Interestingly, a group of genes that appeared to be re-
pressed by STAT5a (cluster 9) also exhibited enrichment for
theGASmotif confirming that STAT5a binding can be also
associated with gene repression. On the other hand, clus-
ters 4–5 and 6, characterized by lower targets enrichment
for STAT5a and at the same time binding from LSD1 and
HDAC3, did not present any enrichment for the GAS mo-
tif, but for other motifs (the TTATC, the TGA(G/C)TCA
and the GGAA that resembles the STAT5 monomer mo-
tif). Similarly, cluster 7 showed only a modest enrichment
for the GAS motif (E-value = 3.8 × 10−46) suggesting that
the binding events occurring in clusters 4–7 might not be
driven by STAT5a/LSD1/HDAC3 complexes alone. Dif-
ferent mechanisms seem to dictate gene regulation, as KD
of STAT5a or LSD1 in clusters 4–6 activated transcription,
in contrast to cluster 7, where KD of STAT5a or LSD1 re-
pressed transcription, albeit not significantly in the case of
LSD1 (Figure 3, Supplementary Figure S5).
To provide further insight into the mechanisms of syner-
gistic regulation exerted by STAT5a, LSD1 and HDAC3,
the genomic location of binding was defined per cluster
(Figure 3E). Interestingly, the gene sets of clusters 4–5, 6
and 7 exhibited increased occurrences of promoter bind-
ing compared to the other clusters, with significantly de-
creased occurrences of intergenic binding. By contrast, clus-
ters with strong STAT5 binding and weak LSD1/HDAC3
binding (1–3) or STAT5 binding only (8–10) were charac-
terized with increased frequencies of intergenic and intronic
binding, suggesting that such regions may function as distal
enhancer elements. Furthermore, to ensure that the effect
seen in the clusters commonly regulated by STAT5a, LSD1
and HDAC3 was not due to low-level ChIP-seq promoter
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binding, and as such an artefact, the motif analysis was re-
peated in only the intronic and intergenic regions per clus-
ter yielding almost identical results (Supplementary Figure
S7).
Overall, genes regulated by the combined action of
STAT5a, LSD1 and HDAC3, appear to be differentially
regulated based on targets enrichment and the genomic
localization of the STAT5a (and its interacting partners’)
binding. Importantly, the combined action of STAT5a,
LSD1 and HDAC3 was distinguished by the absence of the
canonical GASmotif and was found more frequently in the
promoter regions, indicating that the overall STAT5a bind-
ing may be stabilized by additional transcription factors,
chromatin remodelers bound nearby or nucleosomes direct-
ing promoter structure dynamics. These factors might also
contribute directly or indirectly to the recruitment of LSD1
and HDAC3. By contrast, strong STAT5 binding was ob-
served in intergenic and intronic regions, which may func-
tion as enhancer elements from a distance.
Concomitant binding and co-regulation of novel targets by
STAT5 and LSD1
Next, we identified 5187 common peaks, corresponding to
3465 genes by direct STAT5a and LSD1 peak overlaps (i.e.
all overlapping genomic regions of the peak windows, Fig-
ure 4A and B). Motif analysis performed on these common
targets (5187 sequences) detected the GAS motif in 121 se-
quences (E-value = 2.3 × 10−62) and the GGAA motif in
2012 sequences (E-value= 5.7× 10−145), whereas whenmo-
tif analysis was performed in the regionswith promoter only
binding (1418 promoter sequences) 63 sequences contained
the GAS motif (E-value = 9.6 × 10−33) and 500 sequences
contained the GGAA motif (E-value = 9.8 × 10−24).
The overlapping binding sites of STAT5a and LSD1 as
shown by the ChIP-seq data, in conjunction with the RNA-
seq expression profiles in the KD cells, suggest that LSD1
and STAT5a synergistically co-regulate a sub-population
of STAT5 target genes. To investigate the potential co-
regulation of genes bound by STAT5a and LSD1, a few
individual genes exhibiting binding from both factors were
selected and further characterized. All selected genes (Inter-
leukin 4 receptor alpha chain – Il4ra, Growth factor inde-
pendent 1B transcription repressor – Gfi1b and Cannabi-
noid receptor 2 – Cnr2) displayed binding from both
STAT5a and LSD1 at the same genomic location (direct
overlap), on intronic sequences or upstream the TSS (Fig-
ure 4C).
Gfi1b and Cnr2 genes were repressed by IL-3, whereas
Il4ra gene was activated by IL-3 stimulation (Figure 4D).
To test whether co-regulation depended on the concomi-
tant or sequential binding of STAT5a and LSD1, re-ChIP
assays were performed in WT Ba/F3 cells post IL-3 stimu-
lation. The eluate obtained from the ChIP against STAT5a
was used as input for a second ChIP against LSD1. The re-
verse experiment was also performed. The simultaneous co-
occupancy of STAT5 and LSD1 on Il4ra, Gfi1b and Cnr2
peak sequences was confirmed (Figure 4E). Furthermore,
ChIP assays in STAT5a KD and LSD1 KD cells demon-
strated that KD of STAT5a or LSD1 decreases the recruit-
ment of the complex containing STAT5a and LSD1 to the
Il4ra loci (Supplementary Figure S8), suggesting that this
gene is co-regulated by both factors.
In conclusion, our data provide evidence for concomi-
tant binding of STAT5a and LSD1 in the selected activated
and repressed target genes suggesting a synergistic STAT5a
and LSD1 action. As a proof-of-principle, functional data
were presented for a specific STAT5a target gene (Il4ra)
highlighting that regulation of Il4ra gene depends on both
STAT5a and LSD1 factors and their interaction. These
findings lay the ground for future studies on more complex
transcription factors and chromatin interaction networks
that require and maintain such tight synergistic regulation
and define transcription amplitude and variability.
DISCUSSION
STAT proteins rarely act alone in transcriptional regulation
and often depend on direct interactions with other part-
ners to exert their regulatory function, as in the case of
STAT5 and glucocorticoid receptor interaction (34). Here,
by applying proteomics and genomics approaches, insights
in STAT5-dependent activation and repression of target
genes in IL-3 stimulated pro-B cells were provided. Many
genomic targets were identified, which were correlated to
the expression levels of both WT and KD cells. This ap-
proach, apart fromSTAT5a induced genes, revealed various
target genes that were repressed by STAT5a. Motif analysis
showed a significant enrichment of the canonical STAT5a
dimer (GAS) motif, not only in activated, but also in re-
pressed genes (Figure 3, cluster 9) suggesting that binding of
STAT5a on the GAS motif can induce activation or repres-
sion. Thus, additional STAT5a interacting partners could
direct transcription through recruitment of particular fac-
tors.
To identify the mechanisms by which STAT5a regulates
transcription, novel interacting partners obtained from the
proteomics data (LSD1 and HDAC3) were investigated as
potential STAT5a co-regulators. The effect of these inter-
actions on target genes transcription was determined at a
genome-wide level. Both LSD1 and HDAC3 exert tran-
scriptional regulation at STAT5a targets and show dual
roles, being involved in their activation or repression. LSD1
is the first identified histone demethylase (35) capable of ei-
ther repressing or activating target genes by interacting with
various co-factors and catalyzing demethylation of mono-
(M1) and di-methylated (M2) H3-K4 or K9 (36). LSD1
drives target activation by removing the repressive H3-
K9(M2)mark (37,38), whereas it leads to gene repression by
demethylating H3-K4(M1) and (M2) (35,39,40). HDAC3
is responsible for the deacetylation of lysine residues on
the N-terminal tail of core histones and, through multi-
protein complexes, regulates gene transcription being a
locus-specific co-repressor recruited to promoters to re-
press genes regulated by nuclear hormone receptors and
other transcription factors (41). In terms of protein inter-
actions, HDAC3 forms multi-protein complexes with the
co-repressors SMRT and N-CoR (42,43), and STAT5 is
known to interact with SMRT (44). LSD1 forms a complex
with CoREST (45) and is reported to interact with HDAC3
(46) or N-CoR (40). Considering all these reported inter-
actions and our findings, it is possible that STAT5 exists
Nucleic Acids Research, 2017, Vol. 45, No. 1 151
Figure 4. Co-regulation of novel targets by STAT5 and LSD1. (A) Venn diagram showing common binding peaks of the STAT5a and LSD1 ChIP-seq
libraries (from two independent ChIP assays per factor) in Ba/F3 cells after 6 h IL-3 deprivation followed by 30 min IL-3 stimulation. Only direct overlap
of the peak sequence window was considered. (B) Genomic distribution of common STAT5a and LSD1 peaks (direct overlapping peaks only), as reported
by HOMER. (C) UCSC representation of three genes (Il4ra,Gfi1b andCnr2) that display binding of both STAT5a and LSD1 protein at the same genomic
location. The common STAT5a and LSD1 binding is highlighted with a black box. The axes on the left indicate peak scores as produced by Homer
(position-adjusted reads from initial peak region). (D) RNA-seq experiments were performed in WT Ba/F3 cells (N= 5), and cells with KD of STAT5a or
LSD1 (N = 3) or cells treated with control no-target shRNA (N = 5) and are presented in heatmaps. All expression heatmaps represent log2FC values, as
computed by DESeq2 (red depicts up-regulation as 2.0 ≥ log2FC ≥ 0; green depicts down-regulation as 0 ≥ log2FC ≥ -1.4). Differential gene expression
was analyzed against IL-3 deprived cells in the case of WT Ba/F3 cells, and against cells treated with control no-target shRNA at the same condition for
all the KD cells (IL-3 stimulation). The differential expression levels of Il4ra, Gfi1b and Cnr2 are depicted. (E) ChIP-re-ChIP assays were performed in
Ba/F3 cells after IL-3 stimulation using antibodies against STAT5a and LSD1 proteins. The first ChIP was performed using the anti-STAT5a antibody,
and the eluate was used at a second ChIP with the anti-LSD1 antibody. Relative enrichment values versus input were determined by real time PCR and
depict binding from both STAT5a and LSD1 proteins. Error bars display ± SEM (three measurements) and stars show statistical significance (Student’s
t-test, P ≤ 0.05).
in complexes containing SMRT/N-CoR-HDAC3 and/or
LSD1. Furthermore, interactions of HDAC1 or HDAC3
with RUNX1 (47), which inhibits STAT5 transcriptional
activity and can itself be inhibited by STAT5 (14), open the
way for future investigations on the potential involvement
of RUNX1 in the complexes identified.
Genomic targets of both LSD1 and HDAC3 were iden-
tified though ChIP-seq experiments in IL-3 deprived and
stimulated Ba/F3 cells. More than half of LSD1 targets
were retained in both cell states indicating that these were
IL-3-independent. However, differential LSD1 recruitment
was also seen with de novo genomic targets between the two
conditions suggesting that LSD1 plays an important role
in regulating transcription. The distinct LSD1 genomic tar-
gets between the two states corroborate its dual role in gene
repression and activation depending on the substrate for
demethylation. On the other hand, HDAC3, which is linked
closely to gene repression, appeared to have amarked reduc-
tion in recruitment to its targets upon IL-3 stimulation. This
suggests that during IL-3 stimulation, the need for gene re-
pression is greatly reduced and only a few de novo HDAC3
genomic targets are introduced.
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Furthermore, LSD1 and HDAC3 exhibited many unique
and common targets with STAT5a. We found both LSD1
and HDAC3 to have a repressive role in all common
STAT5a, LSD1 and HDAC3 targets (Figure 3, clusters 1–
6), with the exception of a fraction of the common tar-
gets that appears to be induced by both STAT5a and LSD1
(cluster 7). Such a dual function in transcription for LSD1
has been previously described, as for example in the regula-
tion of androgen receptor transcriptional activity (37,48).
This particular cluster (cluster 7), characterized by high
frequency of promoter binding of LSD1 and STAT5a, in-
cluded genes that are activated after IL-3 stimulation and
they show decreased enrichment of the canonical GAS mo-
tif, known to mediate STAT5a binding to DNA. Thus, it
is possible that induction of these genes by the synergistic
action of STAT5a and LSD1 might not be facilitated by
STAT5a, but either by LSD1 or by some other cofactor sta-
bilizing the protein complex on the DNA.
Focusing on the mechanisms of combinatorial regulation
of target genes by STAT5a, LSD1 and HDAC3, motif anal-
ysis revealed a high enrichment of the GASmotif in all gene
sets, except the ones exhibiting LSD1 and HDAC3 bind-
ing, but only with weaker STAT5a binding (clusters 4–5, 6
and 7). Strong STAT5 binding in GASmotifs was observed
in intergenic regions or introns, which may have putative
enhancer activity. However, in the case of weaker STAT5a
binding, the absence of GAS motif in the targets exhibiting
common STAT5a, LSD1 and HDAC3 binding is of partic-
ular interest, as it suggests that STAT5a regulatory control
is not mediated by the genomic interaction of STAT5a it-
self. In these clusters (clusters 4–7), the binding events occur
mainly in promoter regions, whereas in the rest of the clus-
ters in intergenic and intronic regions. The targets belong-
ing to clusters 4–5, which exhibited increased LSD1 and
HDAC3 binding, were repressed by STAT5a, LSD1 and
HDAC3. The absence of a GAS motif could signify that
the interaction is not dependent on the binding of a dimer
STAT5 molecule. The other enriched motifs found in this
group of genes include the recognition sequences for GATA
factors (TTATC or GATAA), for factors belonging to the
ETS family (GGAA or TTCC) and for factors belonging
to leucine zipper family, such as c-fos, c-jun, myc family
and others (TGA(G/C)TCA). Based on these findings, it is
not unlikely for the DNA STAT5a binding to be mediated
through binding of a GATA member or of factors belong-
ing to leucine zipper family. Binding of an ETS familymem-
ber, as part of protein complex containing STAT5a is also
possible, as it is known that in response to IL-2 in human T
lymphocytes a STAT5-ETS protein interaction is seen (49).
In addition, a recent study suggested that EWS/ETS fu-
sion transcription factor could recruit LSD1, which in turn
could recruit either the repressive NuRD complex or co-
activator complex to direct transcription (50).
When considering, however, all targets exhibiting weaker
LSD1 and HDAC3 binding (clusters 6–7), then two differ-
ent transcriptional profiles are seen; repressed genes by IL-
3, STAT5a and LSD1 and activated genes by IL-3, STAT5a
and LSD1. The difference between the two groups is higher
enrichment of theGGAAmotif (ETS family recognition se-
quence) for the repressed genes by STAT5a and LSD1 (clus-
ter 6), and the presence of GASmotif, albeit of very low en-
richment compared to rest of the clusters, for the activated
genes by STAT5a and LSD1 (cluster 7). Since the GGAA
motif resembles the monomer STAT5motif, one hypothesis
could be that genomic interaction could occur through ei-
ther binding of a free STAT5a monomer or binding of one
of the two monomers building a dimer to a specific position
and of the second one to a distant genomic location (e.g.
via chromatin looping), potentially stabilized by co-binding
of the other factors nearby. Monomer STAT5 has been
reported to possess the ability of transcriptional regula-
tion, as tyrosine-unphosphorylated STAT5 monomer colo-
calized with CTCF was found to repress a megakaryocytic
transcriptional program (51). Similarly, unphosphorylated
STAT3 molecules have also been reported to bind to the
GASDNA-binding site as monomers and dimers function-
ing as transcriptional activators and chromatin/genomic
organizers (52).
One could argue that low level ChIP-seq signal could be
an artefact explaining the absence of GAS motif. However,
it is not uncommon to observe genomic binding in the ab-
sence of specific recognition sequence. For example, in GH
stimulated mouse embryonic fibroblasts isolated from WT
or overexpressing STAT5a mice, only 60% of the binding
sites contained GAS motif (53) and similar findings were
obtained in mammary tissue with the GAS motif being
present only in 50% of the binding events, even in genes de-
fined as regulated by STAT5 based on RNA-seq data (54).
Moreover, in liver homogenates from WT mice, when high
or low STAT5 activity was observed, many of the STAT5
binding events detected did not contain GAS motifs, possi-
bly reflecting either STAT5 binding through non-consensus
sequences or indirect STAT5 binding via other proteins
(55). In addition, out of all the GAS sites in the mouse
genome (more than 1 million), only up to 10% of these
are occupied by STATs at any given moment (56). Thus,
based on our findings and these published observations the
presence of GAS motif does not necessarily correlate with
STAT5 binding and the lack of GAS motifs cannot exclude
binding of STAT5.
Although further studies are still necessary to completely
characterize the STAT5a interaction network, this work im-
portantly has identified multiple parameters influencing the
outcome of STAT5a-dependent transcription. In particu-
lar, the STAT5a interacting partners, the bindingmotif gov-
erning the STAT5a genomic interaction (alone or in multi-
protein complexes), the binding affinity (as indicated by tar-
gets enrichment), as well as the genomic location of the peak
in relation to the TSS of target genes could dictate both
transcription direction and amplitude. Finally, the under-
lying landscape of chromatin/histone targets for LSD1 and
HDAC3 (H3K4 versus H3K9) might play a critical role in
ruling the observed dual functions via locus specific enrich-
ment for one rather than the contrasting mark. The novel
insights on STAT5a-dependent transcriptional mechanisms
provided here form a platform for delineation of the com-
plete STAT5 interactions network in pro-B cell functions
and B-cell development.
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